Showing 1 - 10 of 5,788
Was passiert, wenn der ÖPNV durch neue Mobilitätsdienste wie Fahrzeugsharing oder Ridepooling erweitert wird? Im Fokus dieses Working Papers stehen aktuelle Treiber, aber auch zukünftige Wirkungszusammenhänge, Veränderungspotenziale und Gestaltungsoptionen sowie Folgen für Arbeit und...
Persistent link: https://www.econbiz.de/10013369428
Was passiert, wenn der ÖPNV durch neue Mobilitätsdienste wie Fahrzeugsharing oder Ridepooling erweitert wird? Im Fokus dieses Working Papers stehen aktuelle Treiber, aber auch zukünftige Wirkungszusammenhänge, Veränderungspotenziale und Gestaltungsoptionen sowie Folgen für Arbeit und...
Persistent link: https://www.econbiz.de/10013365024
Persistent link: https://www.econbiz.de/10001997506
Persistent link: https://www.econbiz.de/10003420297
Persistent link: https://www.econbiz.de/10003473940
"The NBER Bulletin on Aging and Health provides summaries of publications like this. You can sign up to receive the NBER Bulletin on Aging and Health by email. This paper provides empirical evidence on how intellectual property (IP) on a given technology affects subsequent innovation. To shed...
Persistent link: https://www.econbiz.de/10003994910
Persistent link: https://www.econbiz.de/10011416999
Do intellectual property (IP) rights on existing technologies hinder subsequent innovation? Using newly-collected data on the sequencing of the human genome by the public Human Genome Project and the private firm Celera, this paper estimates the impact of Celera's gene-level IP on subsequent...
Persistent link: https://www.econbiz.de/10013069502
We investigate whether patents on human genes have affected follow-on scientific research and product development. Using administrative data on successful and unsuccessful patent applications submitted to the US Patent and Trademark Office, we link the exact gene sequences claimed in each...
Persistent link: https://www.econbiz.de/10013013175
Do intellectual property (IP) rights on existing technologies hinder subsequent innovation? Using newly-collected data on the sequencing of the human genome by the public Human Genome Project and the private firm Celera, this paper estimates the impact of Celera's gene-level IP on subsequent...
Persistent link: https://www.econbiz.de/10012462442